Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$106.13 - $120.89 $530,650 - $604,450
5,000 New
5,000 $575,000
Q3 2023

Oct 10, 2023

BUY
$94.73 - $105.13 $378,920 - $420,520
4,000 New
4,000 $386,000
Q3 2022

Oct 19, 2022

BUY
$74.61 - $87.26 $401,401 - $469,458
5,380 New
5,380 $408,000
Q1 2022

Apr 25, 2022

SELL
$80.11 - $90.62 $801,100 - $906,200
-10,000 Closed
0 $0
Q4 2021

Jan 10, 2022

SELL
$79.7 - $88.13 $1.79 Million - $1.97 Million
-22,400 Reduced 69.14%
10,000 $874,000
Q3 2021

Oct 13, 2021

BUY
$81.78 - $95.14 $2.65 Million - $3.08 Million
32,400 New
32,400 $2.65 Million
Q2 2021

Jul 14, 2021

SELL
$85.24 - $94.15 $255,719 - $282,450
-3,000 Closed
0 $0
Q1 2021

Apr 12, 2021

SELL
$83.5 - $98.47 $747,325 - $881,306
-8,950 Reduced 74.9%
3,000 $256,000
Q4 2020

Jan 19, 2021

BUY
$78.07 - $94.43 $542,586 - $656,288
6,950 Added 139.0%
11,950 $1.13 Million
Q3 2020

Oct 09, 2020

SELL
$82.14 - $91.0 $977,466 - $1.08 Million
-11,900 Reduced 70.41%
5,000 $434,000
Q2 2020

Jul 10, 2020

BUY
$80.93 - $91.1 $1.37 Million - $1.54 Million
16,900 New
16,900 $1.48 Million
Q1 2020

Apr 09, 2020

SELL
$70.67 - $99.01 $1.43 Million - $2.01 Million
-20,293 Closed
0 $0
Q4 2019

Jan 10, 2020

BUY
$84.35 - $95.37 $1.71 Million - $1.94 Million
20,293 New
20,293 $1.92 Million
Q2 2019

Jul 24, 2019

SELL
$75.4 - $92.8 $1.01 Million - $1.24 Million
-13,340 Closed
0 $0
Q1 2019

Apr 17, 2019

BUY
$75.32 - $86.15 $778,808 - $890,791
10,340 Added 344.67%
13,340 $1.28 Million
Q3 2018

Oct 29, 2018

BUY
$66.94 - $77.43 $200,820 - $232,290
3,000 New
3,000 $258,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.